Gliomas were also rearranged accounting for their prevalent genetic mutations, especially IDH 1/2 mutation (better prognosis), 1p/19q codeletion (better prognosis), and CDKN2A/B homozygous deletion (worse prognosis). Here, IDH1 is linked to central nervous system cancer.